Apoptosis induced by death receptors

Pharmaceutica Acta Helvetiae

Volumn 74, Issue 2-3, 2000, Pages 281-286

  Schneider, Pascal ^a   Tschopp, Jürg ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Apoptosis; Death receptors; FasL; FLIP; Tumor necrosis factor (TNF)

Indexed keywords

CASPASE 8; FAS ANTIGEN; LIGAND; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; BINDING SITE; CONFERENCE PAPER; CYTOTOXICITY; ENZYME ACTIVITY; IMMUNOLOGY; PROTEIN FAMILY; PROTEIN STRUCTURE; RECEPTOR BINDING; SEQUENCE HOMOLOGY;

ANIMALS; APOPTOSIS; HUMANS; RECEPTORS, CELL SURFACE; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034037333     PISSN: 00316865     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-6865(99)00038-2     Document Type: Conference Paper

References (26)

1. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science. 281:1998;1305-1308.
2. Banner D.W., D'Arcy A., Janes W., Gentz R., Schoenfeld H.J., Broger C., Loetscher H., Lesslauer W. Crystal structure of the soluble human 55 kd TNF receptor-human TNF beta complex: implications for TNF receptor activation. Cell. 73:1993;431-445.
3. Chicheportiche Y., Bourdon P.R., Xu H., Hsu Y.M., Scott H., Hession C., Garcia I., Browning J.L. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272:1997;32401-32410.
4. Chinnaiyan A.M., Tepper C.G., Seldin M.F., O'Rourke K., Kischkel F.C., Hellbardt S., Krammer P.H., Peter M.E., Dixit V.M. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 271:1996;4961-4965.
5. Gravestein L.A., Borst J. Tumor necrosis factor receptor family members in the immune system. Semin. Immunol. 10:1998;423-434.
6. Green D.R., Reed J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
7. Grell M., Douni E., Wajant H., Lohden M., Clauss M., Maxeiner B., Georgopoulos S., Lesslauer W., Kollias G., Pfizenmaier K., Scheurich P. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 Kda tumor necrosis factor receptor. Cell. 83:1995;793-802.
8. Grell M., Zimmermann G., Gottfried E., Chen C.M., Grunwald U., Huang D.C., Lee Y.H., Durkop H., Engelmann H., Scheurich P., Wajant H., Strasser A. Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored. EMBO J. 18:1999;3034-3043.
9. Griffith T.S., Rauch C.T., Smolak P.J., Waugh J.Y., Boiani N., Lynch D.H., Smith C.A., Goodwin R.G., Kubin M.Z. Functional analysis of TRAIL receptors using monoclonal antibodies. J. Immunol. 162:1999;2597-2605.
10. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J.L., Schroter M., Burns K., Mattmann C., Rimoldi D., French L.E., Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature. 388:1997;190-195.
11. Lynch C.N., Wang Y.C., Lund J.K., Chen Y.W., Leal J.A., Wiley S.R. TWEAK induces angiogenesis and proliferation of endothelial cells. J. Biol. Chem. 274:1999;8455-8459.
12. McGeehan G.M., Becherer J.D., Bast R.C. Jr., Boyer C.M., Champion B., Connolly K.M., Conway J.G., Furdon P., Karp S., Kidao S.et al. Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor. Nature. 370:1994;558-561.
13. Mohler K.M., Sleath P.R., Fitzner J.N., Cerretti D.P., Alderson M., Kerwar S.S., Torrance D.S., Otten-Evans C., Greenstreet T., Weerawarna K.et al. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature. 370:1994;218-220.
14. Naismith J.H., Sprang S.R. Modularity in the TNF-receptor family. Trends Biochem. Sci. 23:1998;74-79.
15. Ogasawara J., Watanabe F.R., Adachi M., Matsuzawa A., Kasugai T., Kitamura Y., Itoh N., Suda T., Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature. 364:1993;806-809.
16. Rensing-Ehl A., Frei K., Flury R., Matiba B., Mariani S.M., Weller M., Aebischer P., Krammer P.H., Fontana A. Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur. J. Immunol. 25:1995;2253-2258.
17. Schneider P., Thome M., Burns K., Bodmer J.L., Hofmann K., Kataoka T., Holler N., Tschopp J. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity. 7:1997;831-836.
18. Schneider P., Holler N., Bodmer J.L., Hahne M., Frei K., Fontana A., Tschopp J. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187:1998;1205-1213.
19. Schneider P., Schwenzer R., Haas E., Muhlenbeck F., Schubert G., Scheurich P., Tschopp J., Wajant H. TWEAK can induce cell death via endogenous TNF and TNF receptor 1. Eur. J. Immunol. 29:1999;1785-1792.
20. Tanaka M., Suda T., Haze K., Nakamura N., Sato K., Kimura F., Motoyoshi K., Mizuki M., Tagawa S., Ohga S., Hatake K., Drummond A.H., Nagata S. Fas ligand in human serum. Nature Medicine. 2:1996;317-322.
21. Thome M., Schneider P., Hofmann K., Fickenscher H., Meinl E., Neipel F., Mattmann C., Burns K., Bodmer J.L., Schroter M., Scaffidi C., Krammer P.H., Peter M.E., Tschopp̀ J. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature. 386:1997;517-521.
22. Thornberry N.A., Lazebink Y. Caspases: enemies within. Science. 281:1998;1312-1316.
23. Tschopp J., Irmler M., Thome M. Inhibition of Fas death signals by FLIPs. Curr. Opin. Immunol. 10:1998;552-558.
24. Udenfriend S., Kodukula K. Prediction of ω site in nascent precursor of glycosylphosphatidylinositol protein. Methods in Enzymology. 250:1995;571-583.
25. Wiley S.R., Schooley K., Smolak P.J., Din W.S., Huang C.P., Nicholl J.K., Sutherland G.R., Smith T.D., Rauch C., Smith C.A., Goodwin R.G. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 3:1995;673-682.
26. Zhang X.D., Franco A., Myers K., Gray C., Nguyen T., Hersey P. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma. Cancer Res. 59:1999;2747-2753.